Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al.
Newman
E D
ED
Harrington
T M
TM
Perruquet
J L
JL
Davis
D E
DE
Torretti
D
D
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy / Q000191:economics; D056486:Chemical and Drug Induced Liver Injury; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D006801:Humans; D008107:Liver Diseases / Q000473:pathology; D008727:Methotrexate / Q000009:adverse effects*
D008727:Methotrexate